throbber
Product No. 2002-L0424-003
`
`I N F O R M A T I O N
`
`BULLETIN
`
`AUGUST 2002
`
`U. S.
`
` D E P A R T M E N T O F J U S T I C E
`
`©Porrata Consulting
`
`Introduction
`
`Because the criminal penalties associated with
`GHB (gamma-hydroxybutyrate) have been made more
`stringent and law enforcement pressure has rendered
`GHB more difficult to obtain, the distribution and
`abuse of GHB analogs have become an increasing
`concern. GHB analogs, which include GBL, BD,
`GHV, and GVL, are drugs that possess chemical
`structures that closely resemble GHB. The ingestion of
`any of these analogs produces physiological effects
`similar to the effects associated with GHB abuse—
`relaxation, mild euphoria, and drowsiness. Abusers
`who emerge from a deep sleep or coma caused by
`GHB analogs may become easily agitated and ex-
`tremely combative. GHB analogs are of particular
`concern because they contribute to increasing numbers
`of auto accidents, sexual assaults, and deaths.
`
`While federal law prohibits the sale of analogs
`for human consumption, GHB analogs are available
`legally as industrial solvents used to produce polyure-
`thane, pesticides, elastic fibers, pharmaceuticals,
`coatings on metal or plastic, and other products.
`These analogs also are sold illicitly as supplements
`
`for bodybuilding, fat loss, reversal of baldness,
`improved eyesight, and to combat aging, depression,
`drug addiction, and insomnia. GBL and BD are sold
`as “fish tank cleaner,” “ink stain remover,” “ink
`cartridge cleaner,” and “nail enamel remover” for
`approximately $100 per bottle—much more expen-
`sive than comparable products. Law enforcement’s
`efforts to identify the abuse of GHB analogs are
`hampered by the fact that routine toxicological
`screens do not detect the presence of these analogs. In
`addition, distributors continually develop new ana-
`logs to avoid law enforcement detection.
`
`Analogs
`
`GHB analogs often are abused in place of
`GHB or are used to produce GHB. Common GHB
`analogs include GBL, BD, GHV, and GVL. (See
`Table 1 on page 2.) Both GBL and BD metabolize
`into GHB upon ingestion. GBL is the most com-
`mon precursor used in the production of GHB.
`GVL is abused in place of GHB because it me-
`tabolizes into GHV, which produces physiological
`effects similar to GHB.
`
`JAZZ EXHIBIT 2008
`Par Pharm., Inc. et al. (Petitioners) v. Jazz Pharms., Inc. (Patent Owner)
`Case CBM2014-00151
`
`Page 1 of 8
`
`

`
`GHB Analogs—GBL, BD, GHV, and GVL
`
`Table 1. GHB Analogs
`/emaNlacimehC
`rofrosrucerP
`emaNevitanretlA
`fonoitcudorP
`enotcalorytub-ammag
`ordyh-idenonaruf
`enonarufordyhid
`loidenatub-4,1
`locylgenelyhtemartet
`B-locus
`locylgenelytub
`etarelavyxordyh-ammag
`BHG-lyhtem
`enotcalorelav-ammag
`edilonatnep-4
`
`BHG
`
`LBG
`
`*
`
`VHG
`
`golanA
`
`LBG
`
`DB
`
`VHG
`
`LVG
`
`sezilobateM
`otnI
`
`BHG
`
`BHG
`
`*
`
`VHG
`
`and drowsiness. Such effects are similar to those
`associated with GHB abuse and may resemble the
`results of alcohol intoxication. GHB analogs also
`may increase libido, suggestibility, passivity, and
`cause amnesia—traits that make users vulnerable to
`sexual assault and other criminal acts. Users awak-
`ening or emerging from a coma may exhibit ex-
`treme combativeness, a condition which is also
`observed among those in withdrawal from addiction
`to GHB and its analogs. GHB analogs are known to
`produce side effects such as topical irritation to the
`skin and eyes, nausea, vomiting, incontinence, loss
`of consciousness, seizures, liver damage, kidney
`failure, respiratory depression, and even death. GHB
`analogs are physically addictive, causing addicts to
`experience severe withdrawal symptoms if they
`miss a dose or attempt to stop using the drug.
`
`Some GHB analog abusers begin consuming
`dietary supplements believing the claims made by
`manufacturers, and then find themselves addicted
`to the product. GHB analogs typically are abused
`in place of GHB by users who want to experience
`the effects associated with GHB and who find the
`analogs more widely available or easily obtained.
`Often users are unaware that they are consuming
`an analog and mistakenly believe that the sub-
`stance they are ingesting is GHB. Many users mix
`the analogs with flavored beverages to mitigate
`their salty flavor and unappealing odor. Some
`users, however, simply ingest the drugs straight or
`mixed with water. It is often difficult or impossible
`to detect the presence of GBL, BD, GHV, or GVL
`when they are mixed with other liquids because all
`these analogs are clear and colorless. A quick test
`that indicates the possible presence of GHB ana-
`logs or GHB in a clear liquid involves shaking the
`liquid. If it becomes cloudy, GHB analogs or GHB
`may be present.
`
`Because GHB analogs either are metabolized
`into GHB by the human body or produce similar
`physiological effects when ingested, healthcare
`providers often are unable to distinguish between
`the abuse of GHB and GHB analogs. Thus, the
`rising abuse of GHB, evidenced by the increase in
`
`*GHV is not used as a precursor and is not metabolized into
`another drug.
`Abuse
`
`GHB analogs are distributed as liquids and
`consumed orally. When ingested, these analogs
`produce effects such as relaxation, mild euphoria,
`
`Man Drugs Wife and Babysitter With BD
`In March 2002 a South Dakota man was arrested
`for possession of BD and the distribution of BD to
`a minor. The man had purchased a dietary supple-
`ment containing BD from a Canadian company
`over the Internet. The man’s wife believes that her
`husband drugged both her and their babysitter
`with the substance. The man allegedly experi-
`mented with the product on himself in order to
`determine the dosage, in relation to body weight,
`that would achieve the desired effects. On several
`occasions, after consuming mixed drinks her
`husband prepared, the wife fell into a deep sleep
`and vaguely recalled her husband’s having sexu-
`ally abused her. One evening, when both the
`husband and wife had separate plans to be out of
`the house, the wife returned home and found the
`husband at home with the babysitter who said she
`felt drowsy. The babysitter claimed that the hus-
`band had given her something for a headache and
`said she recalled him rubbing her back and touch-
`ing her breasts. The wife immediately took the
`babysitter to the hospital and notified authorities.
`
`Source: Sioux Falls Police Department.
`
`2
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 2 of 8
`
`Page 2 of 8
`
`

`
`Table 2. Emergency Department Mentions for
`GHB and GBL in 22 Major U.S. Cities, 1994–2000
`raeY
`latoT
`
`4991
`
`5991
`
`6991
`
`7991
`
`8991
`
`9991
`
`0002
`
`65
`
`541
`
`836
`
`267
`
`282,1
`
`871,3
`
`969,4
`
`Source: Substance Abuse and Mental Health Services Administra-
`tion, Drug Abuse Warning Network (DAWN).
`
`DAWN emergency department mentions, reflects
`increased GHB analog use as well.
`
`Distribution
`
`GHB analogs are readily available, and various
`methods are used to distribute these drugs. Because
`of legislation (see page 5), GHB analogs are legally
`available only in products not intended for human
`consumption. Abusers and distributors may obtain
`commercial products such as chemical solvents
`legally and then illegally consume or distribute them.
`
`BD Ingredient in Sleep Aid
`On January 27, 2000, a Utah man died from taking
`Zen, a product containing sucol-B, an alternative
`name for 1,4-butanediol. The man initially purchased
`the product in July 1999 as a sleep aid from a local
`health food store and was unaware that the product
`contained a GHB analog. He realized he had become
`addicted to the substance and was trying to wean
`himself from it before his death. In April 2002 the
`man’s widow reached an undisclosed settlement in a
`case filed in civil court holding the store responsible in
`the wrongful death of her husband, claiming they failed
`to warn consumers that the product contained an
`active ingredient that is processed by the body into
`GHB.
`
`Sources: G. Erick Nielson and Associates (plaintiff’s legal
`representative); Associated Press.
`
`National Drug Intelligence Center
`
`Illegal distribution of GHB analogs often occurs at
`raves, concerts, nightclubs, health clubs, gyms, and
`on college campuses. At these venues GHB analogs
`usually are sold for $10 to $20 per capful (approxi-
`mately 1 teaspoonful). When distributors sell these
`drugs, they may fail to specify which analog they are
`selling, or they may misrepresent the analog as GHB.
`
`GHB analogs also are distributed at disrepu-
`table stores that sell health food and nutritional
`supplements. The analogs also may be marketed on
`the Internet and then shipped to purchasers via
`package delivery services. Typically, analogs are
`marketed as dietary supplements, sleep aids, and
`cleaning products. They are packaged in bottles
`containing 4 to 20 ounces and sold for $40 to $100
`each. The products that are distributed as dietary
`supplements usually contain GVL as the active
`ingredient, while the cleaning supplies usually
`contain GBL or BD. The concentration of the analog
`varies; therefore, the size of a dose may range from
`one-half teaspoon to one-half ounce, and the number
`of doses per bottle may range from 24 to 48.
`
`Individuals who illegally produce GHB analogs
`for human consumption often list alternative chemi-
`cal names to disguise the ingredients. Most users
`recognize the analog by the brand name or through
`advertisements that tout the product as a replacement
`for a similar product that has been removed from the
`market. Products that contained BD or GBL such as
`RenewTrient II, Serenity, Inner-G, Soma Solution,
`and Blue Nitro are no longer sold, primarily because
`of law enforcement pressure, but comparable
`products with similar brand names are available.
`
`GHB analogs often are sold with disclaimers
`that they are not for human consumption; however,
`many of the products have labels implying that the
`product may be ingested. One product marketed as an
`industrial solvent has a label that states “Warning!
`Accidental ingestion of [product] will produce GHB
`in your body. If you ingest some by mistake, don’t
`take alcohol or any other drug!” Another product
`label states “Warning: Accidental ingestion may
`cause… euphoria…increases tactile sensitivity….”
`
`3
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 3 of 8
`
`Page 3 of 8
`
`

`
`GHB Analogs—GBL, BD, GHV, and GVL
`
`GHB Kits
`Between March 22, 1999, and January 20, 2000,
`two brothers operating from Mississippi and South
`Carolina marketed “GHB kits” on the Internet dis-
`guised as computer-cleaning solvents. The kits
`included instructions for producing GHB from GBL
`and contained enough GBL and sodium hydroxide
`(the chemical used to convert GBL to GHB) to make
`15 to 20 doses of GHB; the kits were sold for $55.
`New Jersey Statewide Narcotics Task Force investi-
`gators made nine undercover purchases by commu-
`nicating via web sites and an e-mail account. Police
`seized a 55-gallon drum of GBL and 10 pounds of
`sodium hydroxide from a home owned by the broth-
`ers in Mount Pleasant, South Carolina. On March
`23, 2002, a New Jersey court sentenced the broth-
`ers to 4 years in prison under a plea agreement.
`
`Source: Associated Press.
`
`Many of the products are marketed as “Great House-
`hold Bargains” (GHB) in order to increase their
`exposure to individuals seeking GHB analogs.
`
`In addition to the distribution methods discussed
`previously, supplies, kits, and recipes for producing
`GHB using the GHB analog GBL are marketed and
`sold on the Internet.
`
`Tests for GHB Analogs
`
`Seized GHB analogs frequently are not identified
`because detection of such analogs requires specific
`field and laboratory testing. Three different color
`tests—cobalt nitrate, Marquis reagent, and Mandelin
`reagent—are useful for detecting the presence of GHB
`analogs. (Contact forensic laboratories to obtain
`specific instructions regarding utilizing these test kits.)
`Both the Marquis reagent and the Mandelin reagent
`tests are available commercially.
`
`Routine toxicological screens do not detect
`GHB or GHB analogs; thus, law enforcement
`officers and medical personnel must order specific
`blood and urine tests when they suspect GHB
`analog abuse. Federal, state, and local forensic
`
`4
`
`laboratories may not routinely test for GHB in
`blood or urine. The most common urine tests
`screen only for the “NIDA-5,” five of the most
`commonly abused categories of drugs—amphet-
`amines (amphetamines, methamphetamine),
`cocaine (powdered cocaine, crack), cannabinoids
`(marijuana, hash), opiates (heroin, opium, codeine,
`morphine), and phencyclidine (PCP). GHB in the
`blood or urine can result from the ingestion of
`GHB, GBL, or BD. To yield a reliable result, tests
`for GHB and GHB analogs must be performed not
`long after ingestion. Urine tests for GHB and GHB
`analogs must be performed within 12 hours after
`ingestion, and blood tests must be performed
`within 5 hours.
`
`GHB Factor in Auto Fatality
`On November 21, 2000, a Florida woman under the
`influence of GHB crashed head-on into another car,
`killing a passenger in the other vehicle. Hours before
`the incident, the woman had been arrested after
`passing out at a red light. A Breathalyzer test failed to
`detect alcohol; however, the woman admitted to
`having drunk from a bottle that contained GHB. She
`posted bond and was released. Two weeks before the
`fatal collision, the driver had been ticketed for careless
`driving; police did not detain her because the officer at
`the scene did not smell alcohol and did not know to
`test for GHB.
`
`Source: Florida Department of Law Enforcement; St. Petersburg
`Times.
`
`Because GHB analogs produce effects similar
`to GHB, driving under the influence of the analogs
`is just as dangerous as driving under the influence
`of GHB. As a result, some agencies have adopted
`aggressive strategies for identifying drivers who
`may have consumed GHB. The Pinellas-Pasco
`Medical Examiner’s Office in Florida conducts
`GHB tests on drivers who are suspected of driving
`under the influence (DUI). In 2000 GHB was
`detected in approximately 8 percent of the
`suspected DUI cases that the office examined.
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 4 of 8
`
`Page 4 of 8
`
`

`
`Legislation
`
`Outlook
`
`National Drug Intelligence Center
`
`On February 18, 2000, the “Hillory J. Farias
`and Samantha Reid Date-Rape Prohibition Act of
`1999” (Public Law 106-172) was signed into law,
`legislating GHB as a Schedule I controlled sub-
`stance. GBL was also regulated under this law as a
`List I controlled chemical. Illicit use of GHB
`analogs may now be prosecuted as Schedule I
`substances under 21 U.S. Code § 813.
`
`GHB analogs are treated as controlled sub-
`stances under Federal law only if intended for
`human consumption. According to 21 U.S.C. § 813,
`“a controlled substance analog(ue) shall, to the
`extent intended for human consumption, be treated,
`for the purposes of any Federal law as a controlled
`substance in Schedule I.” Thus, authorities can
`prosecute drug offenses involving GHB analogs in
`the same manner as offenses involving GHB. (See
`21 U.S.C. § 802(32) for the definition of a con-
`trolled substance analog(ue).)
`
`Deterring the distribution and abuse of GHB
`analogs poses unique challenges. Some analogs
`have legitimate purposes and are legally available.
`Distributors of illicit GHB analogs will continue to
`develop new products to disguise their activities,
`and illicit producers will continue to develop new
`GHB analogs for the same reasons. Web sites
`advertising these products will continue to be
`deceptive and ever-changing. Distributors will
`develop new disguises for GHB analogs in addi-
`tion to marketing them as cleaning fluids and
`dietary supplements. Sharing current information
`and associated trends relating to GHB analogs
`among medical personnel, law enforcement officers,
`and laboratory personnel is essential to stemming
`the distribution and abuse of these analogs.
`
`5
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 5 of 8
`
`Page 5 of 8
`
`

`
`GHB Analogs—GBL, BD, GHV, and GVL
`
`Sources
`
`Annals of Emergency Medicine
`Associated Press
`Broward County (FL) Commission on Substance Abuse
`Emedicine, www.emedicine.com
`Florida Department of Law Enforcement
`G. Erick Nielson and Associates
`Hazeldon Foundation
`Journal of Medicinal Chemistry
`Journal of the Clandestine Laboratory Investigating Chemists Association
`Missouri State Highway Patrol
`Neuropharmacology
`New England Journal of Medicine
`Pennsylvania Attorney General, Bureau of Narcotics Investigation and Drug Control
`Porrata Consulting, Inc.
`Sioux Falls Police Department
`St. Petersburg Times
`U.S. Code Title 21, Food and Drugs
`U.S. Department of Health and Human Services
`Food and Drug Administration
`National Institutes of Health
`National Institute on Drug Abuse
`Community Epidemiology Work Group
`Substance Abuse and Mental Health Services Administration
`Drug Abuse Warning Network
`U.S. Department of Justice
`Drug Enforcement Administration
`Philadelphia Division
`St. Louis Division
`United Nations Office for Drug Control and Crime Prevention
`WebMD Medical News, onhealth.webmd.com
`
`6
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 6 of 8
`
`Page 6 of 8
`
`

`
`This page intentionally left blank.
`
`National Drug Intelligence Center
`
`7
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 7 of 8
`
`Page 7 of 8
`
`

`
`GHB Analogs—GBL, BD, GHV, and GVL
`
`032803
`
`319 Washington Street 5th Floor, Johnstown, PA 15901-1622 • (814) 532-4601
`NDIC publications are available on the following web sites:
`http://ndicosa
`LEO
`home.leo.gov/lesig/ndic
`ndic.riss.net
`INTERNET
`www.usdoj.gov/ndic
`
`ADNET
`RISS
`
`This document may contain dated information. It has been made available to provide access to historical materials.
`
`ARCHIVED
`
`Page 8 of 8
`
`Page 8 of 8

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket